Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories

Journal of Molecular and Cellular Cardiology

Volumn 85, Issue , 2015, Pages 79-88

  Hwang, Hyun Seok ^a   Kryshtal, Dmytro O ^a   Feaster, T K ^a   Sánchez Freire, Verónica ^c   Zhang, Jianhua ^d   Kamp, Timothy J ^d   Hong, Charles C ^a,b   Wu, Joseph C ^c   Knollmann, Björn C ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Research Medicine   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CALCIUM CHANNEL L TYPE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SODIUM CALCIUM EXCHANGE PROTEIN; CALCIUM;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM METABOLISM; CALCIUM TRANSPORT; CELL CAPACITANCE TO CELL VOLUME RATIO; CELL ISOLATION; CELL VOLUME; CELLULAR CALCIUM HANDLING; CELLULAR PARAMETERS; CRYOPRESERVATION; CYTOPLASMIC CALCIUM BUFFERING; CYTOSOL; HEART MUSCLE CELL; HEART VENTRICLE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RABBIT; SARCOPLASMIC RETICULUM; ANIMAL; CALCIUM SIGNALING; CARDIAC MUSCLE CELL; CELL CULTURE; CELL DIFFERENTIATION; COMPARATIVE STUDY; HEART CONTRACTION; INDUCED PLURIPOTENT STEM CELL; METABOLISM; PHYSIOLOGY;

MAMMALIA; ORYCTOLAGUS CUNICULUS;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RABBITS; SARCOPLASMIC RETICULUM;

EID: 84930193991     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.05.003     Document Type: Article

References (42)

1. Jafri M.S. Models of excitation-contraction coupling in cardiac ventricular myocytes. Methods Mol Biol 2012, 910:309-335.
2. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
3. Takahashi K., Okita K., Nakagawa M., Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007, 2:3081-3089.
4. Knollmann B.C. Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model?. Circ Res 2013, 112:969-976. discussion 76.
5. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007, 1:39-49.
6. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007, 25:1015-1024.
7. Zhang J., Klos M., Wilson G.F., Herman A.M., Lian X., Raval K.K., et al. Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method. Circ Res 2012, 111:1125-1136.
8. Burridge P.W., Matsa E., Shukla P., Lin Z.C., Churko J.M., Ebert A.D., et al. Chemically defined generation of human cardiomyocytes. Nat Methods 2014, 11:855-860.
9. Yang X., Pabon L., Murry C.E. Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Res 2014, 114:511-523.
10. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415:198-205.
11. Lee Y.K., Ng K.M., Lai W.H., Chan Y.C., Lau Y.M., Lian Q., et al. Calcium homeostasis in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Rev 2011, 7:976-986.
12. Fearnley C.J., Roderick H.L., Bootman M.D. Calcium signaling in cardiac myocytes. Cold Spring Harb Perspect Biol 2011, 3:a004242.
13. O'Rourke B., Kass D.A., Tomaselli G.F., Kääb S., Tunin R., Marbán E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. Circ Res 1999, 84:562-570.
14. Pogwizd S.M., Qi M., Yuan W., Samarel A.M., Bers D.M. Upregulation of Na(+)/Ca(2+) exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res 1999, 85:1009-1019.
15. Itzhaki I., Rapoport S., Huber I., Mizrahi I., Zwi-Dantsis L., Arbel G., et al. Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PLoS One 2011, 6. e18037.
16. Liang P., Lan F., Lee A.S., Gong T., Sanchez-Freire V., Wang Y., et al. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation 2013, 127:1677-1691.
17. Lan F., Lee A.S., Liang P., Sanchez-Freire V., Nguyen P.K., Wang L., et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 2013, 12:101-113.
18. Sun N., Yazawa M., Liu J., Han L., Sanchez-Freire V., Abilez O.J., et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 2012, 4. 130ra47.
19. Zhang G.Q., Wei H., Lu J., Wong P., Shim W. Identification and characterization of calcium sparks in cardiomyocytes derived from human induced pluripotent stem cells. PLoS One 2013, 8. e55266.
20. Sharma A., Marceau C., Hamaguchi R., Burridge P.W., Rajarajan K., Churko J.M., et al. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform. Circ Res 2014, 115:556-566.
21. Yang T., Chun Y.W., Stroud D.M., Mosley J.D., Knollmann B.C., Hong C., et al. Screening for acute IKr Block is insufficient to detect torsades de pointes liability: role of late sodium current. Circulation 2014, 130:224-234.
22. Yu J., Hu K., Smuga-Otto K., Tian S., Stewart R., Slukvin I.I., et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009, 324:797-801.
23. Okita K., Matsumura Y., Sato Y., Okada A., Morizane A., Okamoto S., et al. A more efficient method to generate integration-free human iPS cells. Nat Methods 2011, 8:409-412.
24. Sanchez-Freire V., Lee A.S., Hu S., Abilez O.J., Liang P., Lan F., et al. Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells. J Am Coll Cardiol 2014, 64:436-448.
25. Knollmann B.C., Chopra N., Hlaing T., Akin B., Yang T., Ettensohn K., et al. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J Clin Invest 2006, 116:2510-2520.
26. Satoh H., Delbridge L.M., Blatter L.A., Bers D.M. Surface:volume relationship in cardiac myocytes studied with confocal microscopy and membrane capacitance measurements: species-dependence and developmental effects. Biophys J 1996, 70:1494-1504.
27. Trafford A.W., Diaz M.E., Eisner D.A. A novel, rapid and reversible method to measure Ca buffering and time-course of total sarcoplasmic reticulum Ca content in cardiac ventricular myocytes. Pflugers Arch 1999, 437:501-503.
28. Schober T., Huke S., Venkataraman R., Gryshchenko O., Kryshtal D., Hwang H.S., et al. Myofilament Ca sensitization increases cytosolic Ca binding affinity, alters intracellular Ca homeostasis, and causes pause-dependent Ca-triggered arrhythmia. Circ Res 2012, 111:170-179.
29. Bers D.M. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 2000, 87:275-281.
30. Puglisi J.L., Goldspink P.H., Gomes A.V., Utter M.S., Bers D.M., Solaro R.J. Influence of a constitutive increase in myofilament Ca(2+)-sensitivity on Ca(2+)-fluxes and contraction of mouse heart ventricular myocytes. Arch Biochem Biophys 2014, 552-553:50-59.
31. Berlin J.R., Bassani J.W., Bers D.M. Intrinsic cytosolic calcium buffering properties of single rat cardiac myocytes. Biophys J 1994, 67:1775-1787.
32. Lundy S.D., Zhu W.Z., Regnier M., Laflamme M.A. Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev 2013, 22:1991-2002.
33. Diaz M.E., Trafford A.W., Eisner D.A. The role of intracellular Ca buffers in determining the shape of the systolic Ca transient in cardiac ventricular myocytes. Pflugers Arch 2001, 442:96-100.
34. Liu J., Fu J.D., Siu C.W., Li R.A. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation. Stem Cells 2007, 25:3038-3044.
35. Dolnikov K., Shilkrut M., Zeevi-Levin N., Gerecht-Nir S., Amit M., Danon A., et al. Functional properties of human embryonic stem cell-derived cardiomyocytes: intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells 2006, 24:236-245.
36. Riedel M., Jou C.J., Lai S., Lux R.L., Moreno A.P., Spitzer K.W., et al. Functional and pharmacological analysis of cardiomyocytes differentiated from human peripheral blood mononuclear-derived pluripotent stem cells. Stem Cell Rep 2014, 3:131-141.
37. Rao C., Prodromakis T., Kolker L., Chaudhry U.A., Trantidou T., Sridhar A., et al. The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials 2013, 34:2399-2411.
38. Chan Y.C., Ting S., Lee Y.K., Ng K.M., Zhang J., Chen Z., et al. Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells. J Cardiovasc Transl Res 2013, 6:989-999.
39. Eschenhagen T., Fink C., Remmers U., Scholz H., Wattchow J., Weil J., et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J 1997, 11:683-694.
40. Germanguz I., Sedan O., Zeevi-Levin N., Shtrichman R., Barak E., Ziskind A., et al. Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells. J Cell Mol Med 2011, 15:38-51.
41. Dolnikov K., Shilkrut M., Zeevi-Levin N., Danon A., Gerecht-Nir S., Itskovitz-Eldor J., et al. Functional properties of human embryonic stem cell-derived cardiomyocytes. Ann N Y Acad Sci 2005, 1047:66-75.
42. Roderick H.L., Knollmann B.C. Inositol 1,4,5-trisphosphate receptors: "exciting" players in cardiac excitation-contraction coupling?. Circulation 2013, 128:1273-1275.